Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells 14,569 Shares of Stock
MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 14,569 shares of the business's stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $7.06, for a total value of $102,857.14. Following the transaction, the insider owned 4,318,348 shares of the company's stock, valued at approximately $30,487,536.88. The trade was a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
NASDAQ:TRDA
